The National Institute for Health and Clinical Excellence (NICE) in the UK makes recommendations to the NHS on the adoption (or continuation) of therapies. This requires judgements about whether the values/weights attached to gains in quality and length of life should vary according to the...

A major issue in health economic evaluation is that of the value to place on a quality adjusted life year (QALY), commonly used as a measure of health care effectiveness across Europe. This critical policy issue is reflected in the growing interest across Europe in development of more sound...

<section xml:id="hec3018-sec-0001" numbered="no"> Background</title> The appropriate thresholds for decisions on the cost‐effectiveness of medical interventions remain controversial, especially in ‘end‐of‐life’ situations. Evidence of the values placed on different types of health gain by the general public is limited.</section> <section xml:id="hec3018-sec-0002" numbered="no"> <title type="main">Methods</title> Across nine...</section>